New Political Economy of Pharmaceuticals

Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.

To come

Zaheer Babar, University of Auckland, New ZealandSudip Chaudhuri, Indian Institute of Management Calcutta, IndiaAnwar Gilani, Aga Khan University, PakistanAndy Gray, University of KwaZulu-Natal, South AfricaMohamed Azmi Ahmad Hassali, Universiti Sains MalaysiaChee-Ruey Hsieh, Academia Sinica, TaiwanRichard Husada, Universitas Surabaya, IndonesiaDina Iskander, Oxfam Novib, Cairo, EgyptShazia Qasim Jamshed, International Islamic University, MalaysiaHans Löfgren, Deakin University, AustraliaMuhammad Ashar Malik, Aga Khan University, PakistanShankaran Nambiar, Manipal International University, MalaysiaJens Plahte, Oslo, NorwaySimon Reid-Henry, Queen Mary, University of London, UKAsrul Akmal Shafie, Universiti Sains MalaysiaCassandra Sweet, PUC, Santiago, ChileJayabalan Thambyappa, Academy of Occupational and Environmental Medicine, MalaysiaRaymond R Tjandrawinata, Dexa Laboratories of Biomolecular Sciences, Tangerang, IndonesiaYousuf A Vawda, University of KwaZulu Natal, South AfricaIpek Eren Vural, Middle East Technical University, Ankara, TurkeyOwain David Williams, Aberystwyth University, WalesBong-min Yang, Seoul National University, South Korea